There are 3163 resources available
Introduction and scientific background
Presenter: Amélie Darlix
Session: Cancer neuroscience in brain tumours and beyond
Resources:
Slides
Webcast
LBA68 - Efficacy and safety of darolutamide plus androgen-deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) from the phase III ARANOTE trial
Presenter: Fred Saad
Session: Mini oral session: GU tumours, prostate
Resources:
Abstract
Slides
Webcast
232O - Effects of a high-intensity exercise intervention on recurrence and survival: The OptiTrain breast cancer trial
Presenter: Helene Rundqvist
Session: Proffered paper session: Breast cancer, early stage
Resources:
Abstract
Webcast
994MO - The updated report of phase I trial of VG2025, a non-attenuated HSV-1 oncolytic virus expressing IL-12 and IL-15/Rα payloads, in patients with advanced solid tumors
Presenter: Yinan Shen
Session: Mini oral session: Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
The value of IARC’s cancer prevention resources in daily clinical practice, and how ESMO is supporting them
Presenter: Elisabete Weiderpass
Session: ESMO-IARC – Medical oncology and cancer prevention: The odd couple?
Resources:
Slides
Webcast
Use of digital symptom reporting in haematological patients
Presenter: Raul Cordoba Mascunano
Session: eHealth and digital innovations
Resources:
Slides
Webcast
Cancer is a family affair
Presenter: Karin Dieperink
Session: ESMO-EONS collaborative session: Caring for the carers
Resources:
Slides
Webcast
Functional pancreatic NETs syndromes
Presenter: Grigorios Kaltsas
Session: Differential diagnosis and management of clinical syndromes
Resources:
Slides
Webcast
What clinicians need to successfully treat AYA patient with cancer
Presenter: Fedro Peccatori
Session: ESMO in collaboration with SIOPE / ESMO AYA: The greatest need for better outcome of Adolescent and Young Adult Cancer (AYA) with cancer
Resources:
Slides
Webcast
Update on adjuvant treatment
Presenter: Tim Meyer
Session: Management of adjuvant/neoadjuvant HCC in 2024
Resources:
Slides
Webcast